View in EDS

Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group.

Saved in:
Bibliographic Details
Title: Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group.
Authors: Papageorgiou, Sotirios G. sotirispapageorgiou@hotmail.com, Kotsianidis, Ioannis1,2, Kontos, Christos K., Symeonidis, Argyris2,3, Galanopoulos, Athanasios2,4, Hatzimichael, Eleftheria, Poulakidas, Elias, Diamantopoulos, Panagiotis, Vassilakopoulos, Theodoros P., Zikos, Panagiotis, Papadaki, Helen, Bouronikou, Eleni, Panayiotidis, Panayiotis, Viniou, Nora-Athina2,5, Pappa, Vasiliki2,6
Source: Leukemia Research. Aug2018, Vol. 71, p55-59. 5p.
Database: Academic Search Ultimate
Description
ISSN:01452126
DOI:10.1016/j.leukres.2018.07.004